LEADER 05886nam 22007814a 450 001 9910455584203321 005 20200520144314.0 010 $a600-00-0402-8 010 $a1-280-50559-1 010 $a9786610505593 010 $a1-60129-419-0 035 $a(CKB)111087027617420 035 $a(EBL)267489 035 $a(OCoLC)171570238 035 $a(SSID)ssj0000139887 035 $a(PQKBManifestationID)11136621 035 $a(PQKBTitleCode)TC0000139887 035 $a(PQKBWorkID)10028642 035 $a(PQKB)11304639 035 $a(MiAaPQ)EBC267489 035 $a(Au-PeEL)EBL267489 035 $a(CaPaEBR)ebr10116487 035 $a(CaONFJC)MIL50559 035 $a(OCoLC)936834565 035 $a(EXLCZ)99111087027617420 100 $a20020712d2002 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aDisease markers in exhaled breath$b[electronic resource] $ebasic mechanisms and clinical applications /$fedited by Nandor Marczin and Magdi H. Yacoub 210 $aAmsterdam ;$aWashington, DC $cIOS Press$dc2002 215 $a1 online resource (443 p.) 225 1 $aNATO science series. Series I, Life and behavioural sciences,$x1566-7693 ;$vv. 346 300 $aAlso published in 2003 in the Lung biology in health and disease series by M. Dekker. 311 $a1-58603-273-9 311 $a0-585-45862-6 320 $aIncludes bibliographical references and index. 327 $a""Cover""; ""Title page""; ""Preface""; ""Sponsors""; ""List of Participants""; ""Contents""; ""Part I. Introduction to Disease Markers in Exhaled Breath""; ""Section 1. Nitric Oxide""; ""Regulation of Nitric Oxide Synthases in the Lung""; ""Nitric Oxide Production in the Lung and its Regulation by Oxygen""; ""S-Nitrosothiols in Respiratory Biology""; ""Inhibitors of Nitric Oxide Synthase: Experimental Findings and Clinical Implications""; ""Inhaled NO as a Replacement Therapy""; ""Physiology of Exhaled Nitric Oxide""; ""The ""Vascular"" Origins of Exhaled Nitric Oxide"" 327 $a""Exhaled NO originates in Airway Epithelium""""NO is Generated via NOS Enzymes""; ""Technical Aspects of Exhaled NO: Investigator Point of View""; ""Technical Aspects of Exhaled Nitric Oxide: Aerocrine Point of View""; ""Section 2. Carbon Monoxide""; ""Cytoprotection by Heme Oxygenase / CO in the Lung""; ""Role of Heme Oxygenase in Airway Smooth Muscle Contractility""; ""Exhaled Carbon Monoxide is Produced in the Lungs""; ""Exhaled Carbon Monoxide is Delivered from Systemic Sources""; ""Kinetics of Carbon Monoxide Accumulation in Exhaled Breath"" 327 $a""ETCOc: An Indicator of Hemolysis in Neonatal Hyperbilirubinemia""""Section 3. Volatile Organic Compounds (VOCs)""; ""Volatile Organic Compounds as Exposure Markers""; ""Volatile Organic Compounds as Markers in Normal and Diseased States""; ""Section 4. The ""Living State""""; ""The Living State: Intimate Insights through Personal Discoveries""; ""Part II. Asthma""; ""Biology of Asthma""; ""Transcriptional Regulation of Airway Inflammation""; ""Molecular Mechanisms of Steroid Actions""; ""Nitric Oxide Reactions in the Asthmatic Airway"" 327 $a""Regulation of pH in the Human Airway: Mechanisms and Monitoring""""Markers in Exhaled Air and Condensate to Monitor Treatment in Asthma""; ""Extended NO Analysis Applied to Patients with Known Altered Values of Exhaled NO""; ""Exhaled Nitric Oxide and Atopy""; ""Bradykinin and Exhaled Nitric Oxide in Asthma""; ""Exhaled NO is an Optimal Marker of Severity and Responsiveness to Therapy in Asthma""; ""Superoxide-NO Interactions in Paranasal Sinus Inflammatory Diseases""; ""Part III. Chronic Lung Diseases""; ""Biology, Diagnosis and Management of COPD"" 327 $a""Disease Markers in COPD: Exhaled Breath vs. Exhaled Condensate""""The Biology of Cystic Fibrosis""; ""Exhaled Markers in Cystic Fibrosis""; ""Lung Cancer Screening by Breath Analysis""; ""Nitric Oxide and Rheumatic Diseases""; ""Nitric Oxide in Hepatopulmonary Syndrome""; ""Pathological Changes in the Airways Epithelium of Liquidators of the Chernobyl Catastrophe""; ""Part IV. Transplantation""; ""Heme Oxygenase-1 and/or Carbon Monoxide can Promote Organ Graft Survival""; ""Mechanisms of and Clinical Efforts to Minimise Perioperative Lung Injury"" 327 $a""Condensate Inflammatory Markers in Lung Transplantation"" 330 $aThis monograph contains the contributions of invited speakers and participants at the NATO Advanced Study Institute on Disease Markers in Exhaled Breath: Basic Mechanisms and Clinical Applications, held in Greece in 2001. This ASI was designed to summarize and disseminate expert knowledge regarding this rapidly evolving field of lung biology. Breath testing dates from the earliest history of medicine and puzzled brilliant scientific minds including Linus Pauling. The recent developments hold enormous promise that analysis of exhaled breath could open a valuable new window onto human metabolism 410 0$aNATO science series.$nSeries I,$pLife and behavioural sciences ;$vv. 346. 606 $aLungs$xDiseases$xDiagnosis 606 $aBreath tests 606 $aBiochemical markers 606 $aNitric oxide$xPathophysiology 606 $aCarbon monoxide$xPathophysiology 608 $aElectronic books. 615 0$aLungs$xDiseases$xDiagnosis. 615 0$aBreath tests. 615 0$aBiochemical markers. 615 0$aNitric oxide$xPathophysiology. 615 0$aCarbon monoxide$xPathophysiology. 676 $a616.2/4075 701 $aMarczin$b Na?ndor$f1962-$0895379 701 $aYacoub$b Magdi$0895380 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910455584203321 996 $aDisease markers in exhaled breath$92000306 997 $aUNINA LEADER 02334oam 2200529 450 001 9910713593103321 005 20220401140651.0 035 $a(CKB)5470000002501728 035 $a(OCoLC)1153935149 035 $a(EXLCZ)995470000002501728 100 $a20200511d2020 ua 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aRecommendations by Board of Trustees to remedy inadequate balances in the Social Security trust funds $ecommunication from the Board of Trustees of the Federal Hospital Insurance Trust Fund : transmitting notification of a projection that the asset reserves held in the Federal Hospital Insurance Trust Fund will become inadequate under the meaning of Section 709 of the Social Security Act, pursuant to 42 U.S.C. 910 (a); Aug. 14, 1935, Ch. 531, Title VII, Sec. 709 (as added by Public Law 98-21, Sec. 143); (97 Stat. 102) 210 1$aWashington :$cU.S. Government Publishing Office,$d2020. 215 $a1 online resource (3 pages) 225 1 $aHouse document / 116th Congress, 2d session ;$v116-121 300 $a"May 1, 2020." 300 $a"Referred to the Committee on Ways and Means." 517 $aRecommendations by Board of Trustees to remedy inadequate balances in the Social Security trust funds 606 $aSocial security$zUnited States$xFinance 606 $aHospitalization insurance$zUnited States$xFinance 606 $aFinance$2fast 606 $aHospitalization insurance$xFinance$2fast 606 $aSocial security$xFinance$2fast 607 $aUnited States$2fast 608 $aLegislative materials.$2fast 608 $aLegislative materials.$2lcgft 615 0$aSocial security$xFinance. 615 0$aHospitalization insurance$xFinance. 615 7$aFinance. 615 7$aHospitalization insurance$xFinance. 615 7$aSocial security$xFinance. 712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Ways and Means, 801 0$bGPO 801 1$bGPO 801 2$bGPO 801 2$bOCLCF 801 2$bOCLCQ 801 2$bGPO 906 $aBOOK 912 $a9910713593103321 996 $aRecommendations by Board of Trustees to remedy inadequate balances in the Social Security trust funds$93462243 997 $aUNINA